NCT04912687 - Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients | Biotech Hunter

Enrollment

580

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2027

Conditions

Non Small Cell Lung CancerAdvanced Solid Tumor

Interventions

DIAGNOSTIC_TEST

EGFR gene mutation analysis on liquid biopsy

Blood samples will be collected at inclusion for plasma DNA collection and analysis.

Trial Locations (9)

RECRUITING

Institut Bergonie, Bordeaux

RECRUITING

CHU de Rennes - Hopital Pontchaillou, Rennes

NOT_YET_RECRUITING

Institut de Cancérologie de l'Ouest - Site Paul Papin, Angers

NOT_YET_RECRUITING

CHRU Lille, Lille

RECRUITING

CHU Strasbourg, Strasbourg

RECRUITING

Hospices Civils de Lyon, Lyon

NOT_YET_RECRUITING

Institut Curie, Paris

NOT_YET_RECRUITING

CHU Poitiers, Poitiers

RECRUITING

CHU Nice-Hopital de Cimiel, Nice